Back to LYEL
JPMORGAN CHASE & CO LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
8
Latest value
$427K
Q3 2026
Peak value
$427K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $8K |
| Q4 2025 | $50K |
| Q1 2026 | $28K |
| Q2 2026 | $50K |
| Q2 2026 | $11K |
| Q3 2026 | $39K |
| Q3 2026 | $12K |
| Q3 2026 | $427K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $427K | 44.3K | — | — |
| Q3 2026 | $12K | 1.3K | — | — |
| Q3 2026 | $39K | 4.0K | — | — |
| Q2 2026 | $11K | 895 | — | — |
| Q2 2026 | $50K | 3.9K | — | — |
| Q1 2026 | $28K | 1.5K | — | — |
| Q4 2025 | $50K | 1.6K | — | — |
| Q3 2025 | $8K | 490 | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M